Group One Trading’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96.4K Buy
+20,000
New +$121K ﹤0.01% 4894
2026
Q1
Sell
-9,700
Closed -$101K 8594
2025
Q4
$101K Sell
9,700
-15,100
-61% -$152K ﹤0.01% 5000
2025
Q3
$223K Buy
24,800
+16,800
+210% +$147K ﹤0.01% 4566
2025
Q2
$104K Buy
8,000
+7,600
+1,900% +$114K ﹤0.01% 4925
2025
Q1
$10.1K Sell
400
-32,600
-99% -$969K ﹤0.01% 6256
2024
Q4
$1.13M Buy
33,000
+9,600
+41% +$433K ﹤0.01% 2461
2024
Q3
$1.16M Buy
23,400
+23,200
+11,600% +$1.19M ﹤0.01% 2177
2024
Q2
$12K Buy
+200
New +$11.4K ﹤0.01% 5541
2023
Q4
Sell
-21,100
Closed -$588K 8093
2023
Q3
$588K Buy
21,100
+1,100
+6% +$32.8K ﹤0.01% 2755
2023
Q2
$576K Sell
20,000
-11,100
-36% -$247K ﹤0.01% 2875
2023
Q1
$519K Buy
+31,100
New +$439K ﹤0.01% 2748

Other funds holding RXST

Group One Trading's RXST Position: Q2 2026 in Review

Group One Trading increased its RxSight (RXST) stake by 141% in Q2 2026, buying an estimated $2.78K and bringing the position to 787 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #6842.

Group One Trading first reported a position in RXST in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.41M in Q2 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Group One Trading held 787 shares of RxSight worth $3.79K as of Q2 2026.
  • Group One Trading bought 461 RxSight shares in Q2 2026, an estimated $2.78K.
  • RxSight made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6842 holding.
  • Group One Trading first reported a position in RxSight in Q4 2023 and has held it in 5 quarters since.
  • Group One Trading's RxSight position peaked at $1.41M in Q2 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.